Dermata Therapeutics Inc. Warrant (DRMAW) Key Ratios
$0.00
As on 17-Aug-2026 12:16EDT
Market cap
--
Revenue (TTM)
--
P/E Ratio
--
P/B Ratio
--
Div. Yield
--
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | -- | -- | -- |
| EBIT | -- | -- | -- | -- | -- |
| Net Profit | -60.58 | -74.42 | 18.98 | -1.40 | -28.06 |
| EPS | -54.07 | 55.49 | 90.63 | 25.89 | 14.27 |
| Book Value | -- | -- | -49.34 | -59.79 | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-25 | Dec-24 |
| EBIT-Margin
| -- | -- | -- | -- | -- |
| Net Margin
| -- | -- | -- | -- | -- |
| Return on equity
| -210.20 | -195.84 | -172.35 | -194.20 | -310.44 |
| Return on Capital
| -210.20 | -180.31 | -- | -194.20 | -310.44 |
| Return on Assets
| -150.19 | -136.81 | -112.93 | -132.63 | -213.46 |
| Debt to Equity (x)
| -- | -- | 0.00 | -- | -- |
The underlying data is unavailable.